Data from the St. Jude lifetime cohort study (St. Jude LIFE) revealed that two common biomarkers of cardiac function and damage could...
survivors
Giving childhood cancer survivors the beta blocker carvedilol improved a key biomarker linked to heart damage, suggesting this low-cost therapy...
Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation...
People who survive cancer may be at heightened risk of cardiovascular disease in subsequent years, data suggests.However, heart scans may...
